Cargando…

Pembrolizumab-Induced Rhabdomyolysis in a Clear Cell Renal Cell Carcinoma Patient: A Case Report

Pembrolizumab is one of the approved treatments for many types of cancer including clear cell renal cell carcinoma (ccRCC). It has improved the prognosis of renal cell carcinoma, yet has many possible immune-related side effects. We discuss a rare case of rhabdomyolysis in an ccRCC patient treated w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Altermanini, Mohammad, Ali, Khaled, Alwassiti, Wisam, Almohtasib, Suliman, Omar, Nabil E., Zafar, Abdulaziz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601742/ https://www.ncbi.nlm.nih.gov/pubmed/37900826 http://dx.doi.org/10.1159/000532100

Ejemplares similares

Comparative Effectiveness of Front-Line Ipilimumab and Nivolumab or Axitinib and Pembrolizumab in Metastatic Clear Cell Renal Cell Carcinoma
por: Zarrabi, Kevin K, et al.
Publicado: (2022)

Pembrolizumab and lenvatinib in recurrent ovarian clear cell carcinoma resistant to chemotherapy
por: McNamara, Blair, et al.
Publicado: (2023)

Pathological Complete Response of Metastatic Clear Cell Renal Carcinoma with Pembrolizumab and Axitinib: A Case Report and Review of Literature
por: Beirat, Amir F., et al.
Publicado: (2023)

Pembrolizumab combined with axitinib in the treatment of skin metastasis of renal clear cell carcinoma to nasal ala: A case report
por: Dong, Shuai, et al.
Publicado: (2023)

Lenvatinib plus pembrolizumab versus sunitinib for advanced renal cell carcinoma: Japanese patients from the CLEAR study
por: Eto, Masatoshi, et al.
Publicado: (2022)

Sensory neural hearing loss in Behcet's disease successfully controlled with infliximab, case report and review of literature
por: Faisal, Mohanad, et al.
Publicado: (2022)

Cost-effectiveness and budget impact of pembrolizumab+axitinib versus sunitinib in patients with advanced clear-cell renal cell carcinoma in the Netherlands
por: Xander, Nicolas S. H., et al.
Publicado: (2023)

Characterization and Management of Adverse Reactions From the CLEAR Study in Advanced Renal Cell Carcinoma Treated With Lenvatinib Plus Pembrolizumab
por: Motzer, Robert, et al.
Publicado: (2023)

Symptomatic methemoglobinemia in a patient with metastatic clear cell renal cell carcinoma treated with pembrolizumab and axitinib combination therapy: a case report
por: Olsen, T. Anders, et al.
Publicado: (2021)

A complete durable response of vaginal clear cell carcinoma with pembrolizumab: A case report
por: Porragas-Paseiro, Hector S., et al.
Publicado: (2023)

Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms
por: Grünwald, Viktor, et al.
Publicado: (2023)

A Rare Case of Rhabdomyolysis in a Patient With Pembrolizumab Induced Hypothyroidism
por: Idriss, Setana, et al.
Publicado: (2021)

Diagnostic and Prognostic Biomarkers in Renal Clear Cell Carcinoma
por: Weaver, Chaston, et al.
Publicado: (2022)

The renal clear cell carcinoma immune landscape
por: Saad, Omar A., et al.
Publicado: (2022)

Complete response of mediastinal clear cell sarcoma to pembrolizumab with radiotherapy
por: Marcrom, Samuel, et al.
Publicado: (2017)

A Rare Case of Sunitinib-Induced Rhabdomyolysis in Renal Cell Carcinoma
por: Liman, Andrew D., et al.
Publicado: (2018)

Pembrolizumab Plus Axitinib for Metastatic Papillary and Chromophobe Renal Cell Carcinoma: NEMESIA (Non Clear MEtaStatic Renal Cell Carcinoma Pembrolizumab Axitinib) Study, a Subgroup Analysis of I-RARE Observational Study (Meet-URO 23a)
por: Stellato, Marco, et al.
Publicado: (2023)

Open-Label, Single-Arm Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Clear Cell Renal Cell Carcinoma
por: McDermott, David F., et al.
Publicado: (2021)

Case report: Local cryoablation combined with pembrolizumab to eliminate lung metastases from ovarian clear cell carcinoma
por: Meng, Liangliang, et al.
Publicado: (2022)

Simultaneous renal clear cell carcinoma and primary clear cell carcinoma of the liver: A case report
por: Jiang, Hua, et al.
Publicado: (2020)

Resistance to Pembrolizumab and Axitinib in Renal Cell Carcinoma: Clinical and Genomic Evaluation
por: Vlachostergios, Panagiotis J.
Publicado: (2020)

Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non–Clear Cell Renal Cell Carcinoma
por: McDermott, David F., et al.
Publicado: (2021)

Hepatocellular Carcinoma, Polymyositis, Rhabdomyolysis, and Acute Renal Failure
por: Kim, Mi-Jeong, et al.
Publicado: (2004)

Clear Cell Papillary Renal Cell Carcinoma: A Potential Mimic of Conventional Clear Cell Renal Carcinoma on Core Biopsy
por: Liddell, Heath, et al.
Publicado: (2015)

Update on the treatment of metastatic clear cell and non-clear cell renal cell carcinoma
por: Xu, Kevin Y, et al.
Publicado: (2015)

Clear Cell Adenocarcinoma of the Ureter Similar to Clear Cell Renal Cell Carcinoma Histology
por: Watanabe, Kazuhiro, et al.
Publicado: (2021)

Metastatic clear cell variant of renal cell carcinoma of the mandible: Review and case report
por: Shah, Ajaz, et al.
Publicado: (2016)

Snail heterogeneity in clear cell renal cell carcinoma
por: Zaldumbide, Laura, et al.
Publicado: (2016)

Paraneoplastic Eosinophilia in Clear Cell Renal Cell Carcinoma
por: Zhou, Wei-Wei, et al.
Publicado: (2015)

MET Inhibition in Clear Cell Renal Cell Carcinoma
por: Xie, Zuoquan, et al.
Publicado: (2016)

The epigenetic landscape of clear-cell renal cell carcinoma
por: Kluzek, Katarzyna, et al.
Publicado: (2015)

An Immune Atlas of Clear Cell Renal Cell Carcinoma
por: Chevrier, Stéphane, et al.
Publicado: (2017)

Immune classification of clear cell renal cell carcinoma
por: Su, Sumeyye, et al.
Publicado: (2021)

Emerging Targets in Clear Cell Renal Cell Carcinoma
por: Chen, Yu-Wei, et al.
Publicado: (2022)

Cellular milieu in clear cell renal cell carcinoma
por: Raghubar, Arti M., et al.
Publicado: (2022)

Proteomics Characterization of Clear Cell Renal Cell Carcinoma
por: Miranda-Poma, Jesús, et al.
Publicado: (2023)

Metabolic reprogramming of clear cell renal cell carcinoma
por: Zhu, Haiyan, et al.
Publicado: (2023)

Heart Metastases of Clear Cell Renal Cell Carcinoma
por: Romejko, Katarzyna, et al.
Publicado: (2023)

Antigenic targets in clear cell renal cell carcinoma
por: Schindler, Nicholas R., et al.
Publicado: (2023)

Renal Clear Cell Carcinoma and Tonsil Metastasis
por: Marcotullio, Dario, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ollt929hkiraltp6t66kg1f5j4